Role of pioglitazone treatment on atrial remodeling and atrial fibrillation (AF)promotion in an experimental model of congestive heart failure

dc.contributor.authorKorantzopoulos, P.en
dc.contributor.authorGoudevenos, J. A.en
dc.contributor.authorLiu, T.en
dc.contributor.authorLi, G.en
dc.date.accessioned2015-11-24T18:53:11Z
dc.date.available2015-11-24T18:53:11Z
dc.identifier.issn1556-3871-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18512
dc.rightsDefault Licence-
dc.subjectAngiotensin II Type 1 Receptor Blockers/pharmacologyen
dc.subjectAnimalsen
dc.subjectAtrial Fibrillation/*drug therapy/pathologyen
dc.subjectDisease Models, Animalen
dc.subjectHeart Atria/*drug effects/pathologyen
dc.subjectHeart Failure/*chemically induced/physiopathologyen
dc.subjectHypoglycemic Agents/adverse effectsen
dc.subjectInflammationen
dc.subjectOxidative Stressen
dc.subjectRabbitsen
dc.subjectThiazolidinediones/*adverse effects/pharmacology/therapeutic useen
dc.titleRole of pioglitazone treatment on atrial remodeling and atrial fibrillation (AF)promotion in an experimental model of congestive heart failureen
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.hrthm.2008.01.037-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18362032-
heal.identifier.secondaryhttp://ac.els-cdn.com/S1547527108001227/1-s2.0-S1547527108001227-main.pdf?_tid=cebd1b0f48da22bc3fec20c8c247d710&acdnat=1333963280_d06e21f8d6f3df2d4f28d32c19d5eb94-
heal.journalNameHeart Rhythmen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: